Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency [7]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 6, 2004, Pages 1017-1019

  Lim, W ^a   Moffat, K ^b   Hayward, Catherine P M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANAMNESIS; ANGINA PECTORIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DRUG WITHDRAWAL; HEMATOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; MALE; MUSCLE BLEEDING; OFF PUMP CORONARY SURGERY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; SUBSTITUTION THERAPY; VEIN THROMBOSIS;

AGED; BLOOD LOSS, SURGICAL; CORONARY STENOSIS; DRUG MONITORING; FACTOR XIII; FACTOR XIII DEFICIENCY; FEMALE; HEMATOMA; HUMANS; MALE; PERIOPERATIVE CARE;

EID: 13244298324     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00728.x     Document Type: Letter

References (18)

1. Ikkala E, Nevanlinna HR. Congenital deficiency of fibrin stabilizing factor. Thromb Diath Haemat 1962; 7: 567-71.
2. Ikkala E, Myllyla G, Nevanlinna HR. Transfusion therapy in factor XIII (F.S.F.) deficiency. Scand J Haematol 1964; 1: 308-12.
3. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52.
4. Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995; 73: 247-51.
5. Reed GL, Matsueda GR, Haber E. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin. Thromb Haemost 1992; 68: 315-20.
6. Francis CW, Marder VJ. Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. Blood 1988; 71: 1361-5.
7. Tosetto A, Castaman G, Rodeghiero F. Acquired plasma factor XIII deficiencies. Haematologica 1993; 78: 5-10.
8. Loewy AG, McDonagh J, Mikkola H, Teller DC, Yee VC. Structure and function of factor XIII. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001: 233.
9. Ahmad F, Solymoss S, Poon M-C, Berube C, Sullivan AK. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus. Br J Haematol 1996; 93: 700-3.
10. McDevitt NB, McDonagh J, Taylor HL, Roberts HR. An acquired inhibitor to factor XIII. Arch Intern Med 1972; 130: 772-7.
11. Lorand L, Maldonado N, Fradera J, Atencio AC, Robertson B, Urayama T. Hemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin-stabilizing factor (factor XIII). Br J Haematol 1972; 23: 17-27.
12. Krumdieck R, Shaw DR, Huang ST, Poon MC, Rustagi PK. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstrom's macroglobulinemia. Am J Med 1991; 90: 639-45.
13. Lopaciuk S, Bykowska K, McDonagh JM, McDonagh RP, Yount WJ, Fuller CR, Cooperstein L, Gray A Jr, Lorand L. Differences between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. J Clin Invest 1978; 61: 1196-203.
14. McDonagh J. Structure and function of factor XIII. In: Colman RW, Hirsh J, Marder VJ, Saltzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3th edn. Philadelphia, PA: JB Lippincott Co., 1994: 301.
15. Jennings I, Kitchen S, Woods TA, Preston FE. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003; 1: 2603-8.
16. Anwar R, Miloszewski KJA. Factor XIII deficiency. Br J Haematol 1999; 107: 468-84.
17. Fickenscher K, Aab A, Stuber W. A photometric assay for blood coagulation factor XIII. Thromb Haemost 1991; 65: 535-40.
18. Larsen PD, Wallace JW, Frankel LS, Crisp D. Factor XIII deficiency and intracranial hemorrhages in infancy. Pediatr Neurol 1990; 6: 277-8.